Differential tissue-specific protein markers of vaginal carcinoma

British Journal of Cancer

Volumn 100, Issue 8, 2009, Pages 1303-1314

  Hellman, K ^a   Alaiya, A A ^b   Becker, S ^c   Lomnytska, M ^a   Schedvins, K ^a   Steinberg, W ^d   Hellstrom A C ^a   Andersson, S ^a   Hellman, U ^e   Auer, G ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Institution of Cytological Diagnosis (Kloster Paradiese)   (Germany)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cervicalcarcinoma; Proteomics; Vaginalcarcinoma

Indexed keywords

BILIVERDIN; CYTOSKELETON PROTEIN; DDX48 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HYDROLASE; LIPOCORTIN 2; MOLECULAR MARKER; ONCOPROTEIN; OXIDOREDUCTASE; PEROXIREDOXIN 2; PROTEASOME; PROTEIN; RIBONUCLEASE INHIBITOR; TROPOMYOSIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOPSY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; UTERINE CERVIX CARCINOMA; VAGINA CARCINOMA; VAGINA EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS;

EID: 64949087704     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604975     Document Type: Article

References (120)

1. Abdelhaleem M (2004) Over-expression of RNA helicases in cancer. Anticancer Res 24: 3951-3953
2. Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF, Zhou G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin III EF, Emmert-Buck MR (2002) Proteomic analysis of human prostate cancer. Mol Carcinog 33: 9-15
3. Alaiya A, Roblick U, Egevad L, Carlsson A, Franzen B, Volz D, Huwendiek S, Linder S, Auer G (2000) Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol 21: 1-9
4. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, Ahn WS (2005) Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99: 26-35
5. Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098
6. Bastian BC (199@7) Annexins in cancer and autoimmune diseases. Cell Mol Life Sci 53: 554-556
7. Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Maisonneuve P, Pecorelli S, Odicino F, Heintz AP (2006) Carcinoma of the vulva. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95(Suppl 1): S7-S27
8. Benz J, Hofmann A (1997) Annexins: from structure to function. Biol Chem 378: 177-183
9. Berryman M, Bretscher A (2000) Identification of a novel member of the chloride intracellular channel gene family (CLIC5) that associates with the actin cytoskeleton of placental microvilli. Mol Biol Cell 11: 1509-1521
10. Bosch FX, Munoz N (2002) The viral etiology of cervical cancer. Virus Res 89: 183-190
11. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
12. Brunagel G, Shah U, Schoen RE, Getzenberg RH (2003) Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. J Cell Biochem 89: 238-243
13. Button E, Shapland C, Lawson D (1995) Actin, its associated proteins and metastasis. Cell Motil Cytoskeleton 30: 247-251
14. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172
15. Cathro HP, Stoler MH (2002) Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol 117: 944-951
16. Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YH (2006) DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res 66: 6579-6588
17. Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, Lin KH (2007) Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 7: 155-167
18. Chen J, He QY, Yuen AP, Chiu JF (2004) Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4: 2465-2475
19. Choi YP, Kang S, Hong S, Xie X, Cho NH (2005) Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 5: 1481-1493
20. Choo YC, Anderson DG (1982) Neoplasms of the vagina following cervical carcinoma. Gynecol Oncol 14: 125-132
21. Chuman Y, Bergman A, Ueno T, Saito S, Sakaguchi K, Alaiya AA, Franzen B, Bergman T, Arnott D, Auer G, Appella E, Jornvall H, Linder S (1999) Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett 462: 129-134
22. Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ (2001) Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 21: 1129-1133
23. Ciechanover A, Schwartz AL (2004) The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim Biophys Acta 1695: 3-17
24. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 85: 1558-1570
25. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for Rho C. Nature 406: 532-535
26. Cordin O, Banroques J, Tanner NK, Linder P (2006) The DEAD-box protein family of RNA helicases. Gene 367: 17-37
27. Daling JR, Sherman KJ (1992) Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. IARC Sci Publ 5: 223-241
28. Eddy GL, Marks Jr RD, Miller III MC, Underwood Jr PB (1991) Primary invasive vaginal carcinoma. Am J Obstet Gynecol 165: 292-296; discussion 296
29. Fan J, Ren H, Jia N, Fei E, Zhou T, Jiang P, Wu M, Wang G (2008) DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283: 4022-4030
30. Franzen B, Linder S, Alaiya AA, Eriksson E, Fujioka K, Bergman AC, Jornvall H, Auer G (1997) Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis 18: 582-587
31. Franzen B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, Auer G (1996) Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer 73: 909-913
32. Fu P, Chen J, Tian Y, Watkins T, Cui X, Zhao B (2005) Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor. Cancer Gene Ther 12: 268-275
33. Fujii J, Ikeda Y (2002) Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7: 123-130
34. Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T (2002) Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 21: 1876-1881
35. Geisler JP, Geisler HE, Tammela J, Miller GA, Wiemann MC, Zhou Z (1999) A study of heat shock protein 27 in endometrial carcinoma. Gynecol Oncol 72: 347-350
36. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, Theodorescu D (2002) Rho GDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62: 6418-6423
37. Gillette JM, Chan DC, Nielsen-Preiss SM (2004) Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 92: 820-832
38. Gu Y, Wu SL, Meyer JL, Hancock WS, Burg LJ, Linder J, Hanlon DW, Karger BL (2007) Proteomic analysis of high-grade dysplastic cervical cells obtained from Thin Prep slides using laser capture microdissection and mass spectrometry. J Proteome Res 6: 4256-4268
39. Habermann J, Hellman K, Freitag S, Heselmeyer-Haddad K, Hellström A-C, Shah K, Auer G, Ried T (2004) A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina. Cancer Genet Cytogenet 148: 7-13
40. Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B (1992) Gelsolin gene mutation - at codon 187 - in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 42: 357-359
41. Hasselgren PO, Fischer JE (1997) The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg 225: 307-316
42. Hayes MJ, Moss SE (2004) Annexins and disease. Biochem Biophys Res Commun 322: 1166-1170
43. Hellman K, Alaiya AA, Schedvins K, Steinberg W, Hellstrom AC, Auer G (2004) Protein expression patterns in primary carcinoma of the vagina. Br J Cancer 91: 319-326
44. Hellman U (2002) Peptide mapping using MALDI-TOFMS. In Silberring J, Ekman R (eds). Mass Spectrometry and Hyphenated Techniques in Neuropeptide Research, pp 259-275. Wiley: Hoboken, NJ, USA
45. Hermeking H (2003) The 14-3-3 cancer connection. Nat Rev Cancer 3: 931-943
46. Hermeking H (2006) 14-3-3 proteins and cancer biology. Semin Cancer Biol 16: 161
47. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T (1996) Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93: 479-484
48. Hildesheim A, Han C-L, Brinton LA, Nasca PC, Richarts RM, Jones RB, Ashley RL, Ziegler G, Schiller JT (1997) Sexually transmitted agents and risk of carcinoma of the vagina. Int J Gynecol Cancer 7: 251-255
49. Hirano T, Fujioka K, Franzen B, Okuzawa K, Uryu K, Shibanuma H, Numata K, Konaka C, Ebihara Y, Takahashi M, Kato H, Auer G (1997) Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features. Br J Cancer 75: 978-985
50. Hod Y (2004) Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem 92: 1221-1233
51. Hu LD, Zou HF, Zhan SX, Cao KM (2007) Biphasic expression of Rho GDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. Oncol Rep 17: 1383-1389
52. Huang JS, Chao CC, Su TL, Yeh SH, Chen DS, Chen CT, Chen PJ, Jou YS (2004) Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. Biochem Biophys Res Commun 315: 950-958
53. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M, Yoshiki T (2004) Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci 95: 955-961
54. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW (2004) The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 14:491-499
55. Jazii FR, Najafi Z, Malekzadeh R, Conrads TP, Ziaee AA, Abnet C, Yazdznbod M, Karkhane AA, Salekdeh GH (2006) Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol 12: 7104-7112
56. Joseph P, Lei YX, Whong WZ, Ong TM (2002) Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene. J Biol Chem 277: 6131-6136
57. Kamada S, Kusano H, Fujita H, Ohtsu M, Koya RC, Kuzumaki N, Tsujimoto Y (1998) A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin. Proc Natl Acad Sci USA 95: 8532-8537
58. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632-2641
59. Kapranos N, Kominea A, Konstantinopoulos PA, Savva S, Artelaris S, Vandoros G, Sotiropoulou-Bonikou G, Papavassiliou AG (2002) Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 128: 426-432
60. Kim H, Sengupta A, Glogauer M, McCulloch CA (2008) Filamin A regulates cell spreading and survival via beta1 integrins. Exp Cell Res 314: 834-846
61. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, De Luca C, Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu FF, Tsao MS, Mak TW (2005) DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7: 263-273
62. Kirkbride P, Fyles A, Rawlings GA, Manchul L, Levin W, Murphy KJ, Simm J (1995) Carcinoma of the vagina - experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol 56: 435-443
63. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-298
64. Kowalinski E, Bange G, Wild K, Sinning I (2007) Expression, purification, crystallization and preliminary crystallographic analysis of the proliferation-associated protein Ebp1. Acta Crystallogr Sect F Struct Biol Cryst Commun 63: 768-770
65. Langdon SP, Rabiasz GJ, Hirst GL, King RJ, Hawkins RA, Smyth JF, Miller WR (1995) Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res 1: 1603-1609
66. Lee KA, Kang JW, Shim JH, Kho CW, Park SG, Lee HG, Paik SG, Lim JS, Yoon DY (2005) Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCa T keratinocytes by proteomics. Gynecol Oncol 99: 142-152
67. Lei YX, Chen XM, Wu GR, Chen JK (2006) Abnormal expression of eukaryotic translation factors in malignant transformed human bronchial epithelial cells induced by crystalline nickel sulfide. Biomed Environ Sci 19: 53-60
68. Lemieux P, Oesterreich S, Lawrence JA, Steeg PS, Hilsenbeck SG, Harvey JM, Fuqua SA (1997) The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 17: 113-123
69. Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD (2005) Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci USA 102: 7109-7114
70. Lin YW, Lai HC, Lin CY, Chiou JY, Shui HA, Chang CC, Yu MH, Chu TY (2006) Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. Int J Gynecol Cancer 16: 1216-1224
71. Liu JW, Shen JJ, Tanzillo-Swarts A, Bhatia B, Maldonado CM, Person MD, Lau SS, Tang DG (2003a) Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22: 1475-1485
72. Liu M, Oberg K, Zhou Y (2007) Expression and function of vinculin in neuroendocrine tumors. Tumour Biol 28: 196-204
73. Liu X, Wu Y, Zehner ZE, Jackson-Cook C, Ware JL (2003b) Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell-mediated transfer of chromosome 19 demonstrates reduction of vimentin. Electrophoresis 24: 3445-3453
74. Liu Y, Chen Q, Zhang JT (2004) Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling. J Proteome Res 3: 728-735
75. Maines MD, Mayer RD, Erturk E, Huang TJ, Disantagnese A (1999) The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma - pH and cofactor-specific increase in activity. J Urol 162: 1467-1472
76. Mammas IN, Zafiropoulos A, Spandidos DA (2005) Involvement of the ras genes in female genital tract cancer. Int J Oncol 26: 1241-1255
77. Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R (2007) Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer 7: 169
78. McInroy L, Maatta A (2007) Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 360: 109-114
79. Melle C, Ernst G, Scheibner O, Kaufmann R, Schimmel B, Bleul A, Settmacher U, Hommann M, Claussen U, Eggeling FV (2007) Identification of specific protein markers in microdissected hepatocellular carcinoma. J Proteome Res 6: 306-315
80. Mesaeli N, Phillipson C (2004) Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol Biol Cell 15: 1862-1870
81. Morita A, Miyagi E, Yasumitsu H, Kawasaki H, Hirano H, Hirahara F (2006) Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma. Proteomics 6: 5880-5890
82. Multhoff G (2006) Heat shock proteins in immunity. Handb Exp Pharmacol 172: 279-304
83. Nurmi SM, Gahmberg CG, Fagerholm SC (2006) 14-3-3 proteins bind both filamin and alpha Lbeta2 integrin in activated T cells. Ann NY Acad Sci 1090: 318-325
84. Ogino T, Bandoh N, Hayashi T, Miyokawa N, Harabuchi Y, Ferrone S (2003) Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin Cancer Res 9: 4043-4051
85. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, Ferrone S (2006) HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 66: 9281-9289
86. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujimoto Y, Sakiyama Y, Kobayashi K, Kuzumaki N (1997) Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J 16: 4650-4656
87. Opas M, Szewczenko-Pawlikowski M, Jass GK, Mesaeli N, Michalak M (1996) Calreticulin modulates cell adhesiveness via regulation of vinculin expression. J Cell Biol 135: 1913-1923
88. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE (1997) Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 57: 4111-4117
89. Pardo J, Aisa G, Alava E, Sola JJ, Panizo A, Rodriguez-Spiteri N, Garcia JL, Torre W (2008) Primary mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas. Diagn Mol Pathol 17: 151-158
90. Pawlak G, McGarvey TW, Nguyen TB, Tomaszewski JE, Puthiyaveettil R, Malkowicz SB, Helfman DM (2004) Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer 110: 368-373
91. Pettersson F (1999) Annual report on the results of treatment in gynecologic cancer. FIGO 1987-93 22, Radiumhemmet, Stockholm
92. Qi W, Martinez JD (2003) Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation. Radiat Res 160: 217-223
93. Rabilloud T, Vuillard L, Gilly C, Lawrence JJ (1994) Silver-staining of proteins in polyacrylamide gels: a general overview. Cell Mol Biol (Noisy-le-grand) 40: 57-75
94. Ramsamooj P, Notario V, Dritschilo A (1995) Enhanced expression of calreticulin in the nucleus of radioresistant squamous carcinoma cells in response to ionizing radiation. Cancer Res 55: 3016-3021
95. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL (2003) Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 22: 6194-6203
96. Rivett AJ, Mason GG, Murray RZ, Reidlinger J (1997) Regulation of proteasome structure and function. Mol Biol Rep 24: 99-102
97. Sakai N, Ohtsu M, Fujita H, Koike T, Kuzumaki N (1999) Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells. Exp Cell Res 251: 224-233
98. Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C (2007) Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression. Am J Pathol 171: 1650-1658
99. Scheffner M, Whitaker NJ (2003) Human papillomavirus-induced carcino-genesis and the ubiquitin-proteasome system. Semin Cancer Biol 13: 59-67
100. Shah V, Bharadwaj S, Kaibuchi K, Prasad GL (2001) Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: evidence for Rho kinase pathway. Oncogene 20: 2112-2121
101. Shin DH, Jung S, Park SJ, Kim YJ, Ahn JM, Kim W, Choi W (2005) Characterization of thiol-specific antioxidant 1 (TSA1) of Candida albicans. Yeast 22: 907-918
102. Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J, Shriver C (2003) High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 3: 1863-1873
103. Suh KS, Mutoh M, Gerdes M, Yuspa SH (2005) CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy. J Investig Dermatol Symp Proc 10: 105-109
104. Tatenhorst L, Rescher U, Gerke V, Paulus W (2006) Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Neuropathol Appl Neurobiol 32: 271-277
105. Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson Jr HF (2004) Reduced expression of metastasis suppressor Rho GDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10: 3800-3806
106. Ulmasov B, Bruno J, Woost PG, Edwards JC (2007) Tissue and subcellular distribution of CLIC1. BMC Cell Biol 8: 8
107. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, Muramatsu M, Ouchi Y, Inoue S (2002) Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417: 871-875
108. van Hemert MJ, Steensma HY, van Heusden GP (2001) 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23: 936-946
109. Veenendaal LM, Kranenburg O, Smakman N, Klomp A, Borel Rinkes IH, van Diest PJ (2008) Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol 30: 1-11
110. Wei J, Xu G, Wu M, Zhang Y, Li Q, Liu P, Zhu T, Song A, Zhao L, Han Z, Chen G, Wang S, Meng L, Zhou J, Lu Y, Wang S, Ma D (2008) Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res 28: 327-334
111. Wong CM, Zhou Y, Ng RW, Kung Hf HF, Jin DY (2002) Cooperation of yeast peroxiredoxins Tsa1p and Tsa2p in the cellular defense against oxidative and nitrosative stress. J Biol Chem 277: 5385-5394
112. Wu M, Bai X, Xu G, Wei J, Zhu T, Zhang Y, Li Q, Liu P, Song A, Zhao L, Gang C, Han Z, Wang S, Zhou J, Lu Y, Ma D (2007) Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression. Proteomics 7: 1973-1983
113. Xia Q, Kong XT, Zhang GA, Hou XJ, Qiang H, Zhong RQ (2005) Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer. Biochem Biophys Res Commun 330: 526-532
114. Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T (2002) Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential. Oncogene 21: 8310-8319
115. Yip-Schneider MT, Miao W, Lin A, Barnard DS, Tzivion G, Marshall MS (2000) Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem J 351: 151-159
116. Yoon GS, Lee H, Jung Y, Yu E, Moon HB, Song K, Lee I (2000) Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res 60: 1117-1120
117. Yuan Y, Shen Z (2001) Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response. J Biol Chem 276: 48318-48324
118. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES (2005a) Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 4: 1686-1696
119. Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A, Hamburger AW (2005b) The ErbB3- binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci USA 102: 9890-9895
120. Zimmermann U, Woenckhaus C, Pietschmann S, Junker H, Maile S, Schultz K, Protzel C, Giebel J (2004) Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445: 368-374